Safety of rush subcutaneous immunotherapy administered in real life using an infusion pump

被引:8
|
作者
Uriarte Obando, Silvia Antonieta [1 ]
Sastre Dominguez, Joaquin [1 ,2 ]
机构
[1] Fdn Jimenez Diaz, Dept Allergy, E-28040 Madrid, Spain
[2] Sci & Innovat Minist, Carlos Hlth Inst 3, Network Ctr Biomed Res CIBER Resp Dis CIBERES, Madrid, Spain
关键词
ALLERGEN-SPECIFIC IMMUNOTHERAPY; SCHEDULES;
D O I
10.1016/j.anai.2015.09.004
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:527 / 529
页数:4
相关论文
共 50 条
  • [21] Safety of insulin glulisine compared with insulin aspart administered by continuous subcutaneous insulin infusion (CSII)
    Hanaire-Broutin, H
    Schumicki, DM
    Hoogma, RPLM
    Souhami, E
    DIABETES, 2004, 53 : A4 - A4
  • [22] Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes
    Hoogma, R. P. L. M.
    Schumicki, D.
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (06) : 429 - 433
  • [23] PROPHYLACTIC EFFECT OF SELF-ADMINISTERED PUMP-DRIVEN SUBCUTANEOUS IGG INFUSION IN PATIENTS WITH ANTIBODY DEFICIENCY
    REMVIG, L
    ANDERSEN, V
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 412 - 412
  • [24] A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump
    Raskin, P
    Holcombe, JH
    Tamborlane, WV
    Malone, JI
    Strowig, S
    Ahern, JA
    Lavent, F
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (06) : 295 - 300
  • [25] Levels of Hemolysis Markers in Erythrocyte Concentrates Administered Using a Syringe Infusion Pump
    Gannam, Fernanda Figueiredo
    Belela-Anacleto, Aline Santa Cruz
    Kusahara, Denise Miyuki
    Pedreira, Mavilde Goncalves
    JOURNAL OF INFUSION NURSING, 2018, 41 (03) : 180 - 188
  • [26] TOCOLYSIS FOR RECURRENT PRETERM LABOR USING A CONTINOUS SUBCUTANEOUS INFUSION-PUMP
    ALLBERT, JR
    JOHNSON, C
    ROBERTS, WE
    MARTIN, RW
    GOOKIN, KS
    MORRISON, JC
    JOURNAL OF REPRODUCTIVE MEDICINE, 1994, 39 (08) : 614 - 618
  • [27] Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J.
    Soileau, M.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D.
    MOVEMENT DISORDERS, 2023, 38 : S7 - S8
  • [28] USE OF AN INFUSION SET IN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) THERAPY USING A PERSONAL INSULIN PUMP
    Szewczyk, Alicja
    Tobiasz-Kalkun, Natasza
    Stefanowicz-Bielska, Anna
    Kobos, Ewa
    Mlynarczuk, Miroslawa
    Kapusciok, Justyna
    Michalowska, Jolanta
    PIELEGNIARSTWO XXI WIEKU-NURSING IN THE 21 CENTURY, 2020, 19 (03): : 195 - 197
  • [29] High adherence to hymenoptera venom subcutaneous immunotherapy: a real life Italian experience
    Kamberi, E.
    Brianzoni, M. F.
    Garritani, M. S.
    Antonicelli, L.
    Bonifazi, F.
    Bilo, M. B.
    ALLERGY, 2014, 69 : 400 - 401
  • [30] Risk factors and strategies in nonadherence with subcutaneous immunotherapy: a real-life study
    Yang, Yongshi
    Wang, Yin
    Yang, Lin
    Wang, Jingru
    Huang, Nan
    Wang, Xiaolong
    Hu, Lintao
    Jiang, Qing
    Liu, Guanghui
    Zhu, Rongfei
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (11) : 1267 - 1273